XOMA Royalty Shares Are Trading Higher After the Company Announced Its Economic Interest in Seralutinib, a Phase 3 Asset Studying Pulmonary Arterial Hypertension.
XOMA Royalty Shares Are Trading Higher After the Company Announced Its Economic Interest in Seralutinib, a Phase 3 Asset Studying Pulmonary Arterial Hypertension.
XOMA Royalty Shares在公司宣佈其對Seralutinib的經濟利益後交易上漲，Seralutinib是一個研究肺動脈高壓的三期資產。
XOMA Royalty Shares Are Trading Higher After the Company Announced Its Economic Interest in Seralutinib, a Phase 3 Asset Studying Pulmonary Arterial Hypertension.
XOMA Royalty Shares在公司宣佈其對Seralutinib的經濟利益後交易上漲，Seralutinib是一個研究肺動脈高壓的三期資產。
資訊熱榜
更新時間